RxDoctor Payments Data

Neelakshi Patel, MD

Rheumatology · Campbell, CANPI 1508956475

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 0th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California

Medicare billing

Part B allowed, 2024
$698,745
Medicare patients
428
Services billed
59,796

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Orencia ClickjectAbatacept33$195,727
TymlosAbaloparatide54$146,202
Humira(Cf) PenAdalimumab18$136,065
Cosentyx Sensoready PenSecukinumab15$125,388
EnbrelEtanercept16$115,147
HumiraAdalimumab15$101,855
Cimzia (2 Pack)Certolizumab Pegol11$61,594
KevzaraSarilumab13$61,034
Teriparatide16$32,485
Hydroxychloroquine Sulfate242$11,149
MethotrexateMethotrexate Sodium136$5,670
Celecoxib66$4,005
Leflunomide53$3,633
Sulfasalazine103$2,743
Gabapentin153$2,621

Paid to pharmacies, not to this prescriber.

Other rheumatology in Campbell

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →